New GDUFA Workload Formula Will Not Include Inspections Until FY 2025 Fee-Setting
Executive Summary
Capacity planning adjustment that will help calculate generic drug user fees will not include inspections at first to allow more time for time reporting system implementation.
You may also be interested in...
New Workload Categories Add To FDA Staff Needs, Help Increase User Fees
Postmarketing activities, such as REMS document and annual report reviews, are now part of the formula used to account for workload changes in user fee calculations, which likely helped push fees higher in fiscal year 2024.
US FDA Collects ‘Majority’ Of PDUFA Program Fees After Payment Plea
The revenue is expected to sustain the prescription drug user fee program moving forward after reserves were tapped at the start of fiscal year 2023.
US FDA: Please Pay PDUFA Program Fees ASAP
Carryover funds are limited after the agency's collections schedule was altered by the late user fee program renewal.